This invention provides modified biopolymers comprising biopolymers
attached to at least one non-proteinaceous catalyst capable of
dismutating superoxide in the biological system or precursor ligand
thereof. The invention further provides pharmaceutical compositions
comprising the modified biopolymer and therapeutic methods comprising
administering the modified biopolymer to a subject in need thereof.